Expression and Impact of Adenosine A


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
23 Feb 2023
Historique:
received: 01 02 2023
revised: 16 02 2023
accepted: 20 02 2023
entrez: 11 3 2023
pubmed: 12 3 2023
medline: 15 3 2023
Statut: epublish

Résumé

Increased adenosine A

Identifiants

pubmed: 36901835
pii: ijms24054404
doi: 10.3390/ijms24054404
pmc: PMC10003044
pii:
doi:

Substances chimiques

Adenosine K72T3FS567
Calcium SY7Q814VUP
Receptors, Purinergic P1 0
RNA, Messenger 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Ministerio de Ciencia e Innovación Spain
ID : PID2020-116927RB-C321
Organisme : Fundació Marató de TV3
ID : Marato2015-2030
Organisme : Fundació Marató de TV3
ID : Marato2015-20-31
Organisme : Ministerio de Ciencia e Innovación
ID : PID2020-118511RB-I00
Organisme : Government of Catalonia
ID : SGR2017-1769
Organisme : Government of Catalonia
ID : SGR2017-1604

Références

Pharmacol Ther. 2022 Mar;231:107977
pubmed: 34480967
J Clin Invest. 1997 Jun 1;99(11):2710-8
pubmed: 9169501
Circulation. 2016 Aug 9;134(6):486-98
pubmed: 27462069
Circulation. 2005 Apr 26;111(16):2025-32
pubmed: 15851612
Basic Res Cardiol. 1996;91 Suppl 2:1-8
pubmed: 8957537
Cardiovasc Res. 2015 Apr 1;106(1):76-86
pubmed: 25712961
J Neurochem. 2007 Dec;103(6):2314-26
pubmed: 17944874
J Med Chem. 2003 Jan 30;46(3):319-44
pubmed: 12540230
Cardiovasc Res. 2019 Mar 1;115(3):578-589
pubmed: 30219899
Circulation. 1999 Jun 29;99(25):3300-7
pubmed: 10385506
J Am Coll Cardiol. 2012 Jun 12;59(24):2182-90
pubmed: 22676938
Neurochem Res. 2022 Jun;47(6):1637-1650
pubmed: 35320461
Cardiovasc Res. 1997 Oct;36(1):52-9
pubmed: 9415272
JACC Basic Transl Sci. 2022 Nov 23;8(1):1-15
pubmed: 36777175
FASEB J. 1995 Mar;9(5):359-65
pubmed: 7896004
Basic Res Cardiol. 2016 Jan;111(1):5
pubmed: 26611209
Circulation. 1996 Nov 15;94(10):2551-9
pubmed: 8921800
Cardiovasc Res. 2006 Nov 1;72(2):292-302
pubmed: 17014834
Am J Physiol. 1994 Aug;267(2 Pt 2):H812-20
pubmed: 8067437
Proc Natl Acad Sci U S A. 1998 Jun 9;95(12):6995-9
pubmed: 9618527
Acta Physiol (Oxf). 2022 Apr;234(4):e13736
pubmed: 34709723
Front Cell Neurosci. 2019 Mar 28;13:124
pubmed: 30983976
Eur Heart J. 2011 Mar;32(6):721-9
pubmed: 21177700
Biochem Pharmacol. 2003 May 15;65(10):1675-84
pubmed: 12754103
Circulation. 2012 May 1;125(17):2059-70
pubmed: 22456474
Biochem Pharmacol. 2019 May;163:21-31
pubmed: 30710517
Cardiovasc Res. 2022 Mar 16;118(4):1033-1045
pubmed: 33788918
Circ Res. 2006 Oct 13;99(8):816-28
pubmed: 17038651
Int J Mol Sci. 2021 Mar 27;22(7):
pubmed: 33801676
Cell Signal. 2013 Apr;25(4):736-42
pubmed: 23291003
Circulation. 2006 Dec 5;114(23):2434-42
pubmed: 17101853
Biomed Pharmacother. 2023 Feb;158:114169
pubmed: 36592495
Heart. 1997 Jul;78(1):88-90
pubmed: 9290409

Auteurs

Carmen Tarifa (C)

Biomedical Research Institute of Barcelona, IIBB-CSIC, 08036 Barcelona, Spain.
Institut d'Investigació Biomèdica Sant Pau (IIB Sant Pau), 08025 Barcelona, Spain.

Verónica Jiménez-Sábado (V)

Institut d'Investigació Biomèdica Sant Pau (IIB Sant Pau), 08025 Barcelona, Spain.
Cardiology Department, Hospital de la Santa Creu i Sant Pau, 08025 Barcelona, Spain.
Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV), Instituto de Salud Carlos III, 28029 Madrid, Spain.

Rafael Franco (R)

Departament de Bioquímica i Biomedicina Molecular, Facultat de Biología, Universitat de Barcelona, 08028 Barcelona, Spain.

José Montiel (J)

Cardiac Surgery Department, Hospital de la Santa Creu i Sant Pau, 08025 Barcelona, Spain.

José Guerra (J)

Institut d'Investigació Biomèdica Sant Pau (IIB Sant Pau), 08025 Barcelona, Spain.
Cardiology Department, Hospital de la Santa Creu i Sant Pau, 08025 Barcelona, Spain.
Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV), Instituto de Salud Carlos III, 28029 Madrid, Spain.

Francisco Ciruela (F)

Pharmacology Unit, Department of Pathology and Experimental Therapeutics, Faculty of Medicine and Health Sciences, Institute of Neurosciences, University of Barcelona, 08907 L'Hospitalet de Llobregat, Spain.
Neuropharmacology & Pain Group, Neuroscience Program, Institut d'Investigació Biomèdica de Bellvitge, IDIBELL, 08907 L'Hospitalet de Llobregat, Spain.

Leif Hove-Madsen (L)

Biomedical Research Institute of Barcelona, IIBB-CSIC, 08036 Barcelona, Spain.
Institut d'Investigació Biomèdica Sant Pau (IIB Sant Pau), 08025 Barcelona, Spain.
Cardiology Department, Hospital de la Santa Creu i Sant Pau, 08025 Barcelona, Spain.
Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV), Instituto de Salud Carlos III, 28029 Madrid, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH